The Self-Experimentation Reality Using BPC-157 outside clinical trials means accepting the role of experimental subject without the protections built into formal research
Research on composite peptide preparations such as the four-peptide regenerative complexes explored in recent combination studies including BPC-157, GHK-Cu, TB-500 and Thymosin Alpha-1 has highlighted precisely this synergistic potential, where NO-mediated and VEGF-mediated angiogenic signals from different compounds may produce non-additive outcomes at the tissue level
- Sold from a Licenced Pharmacy in Canada - can be used to reconstitute peptides
Tap the syringe gently to move any bubbles to the top, then push them back into the vial
In animal and emerging human data, it upregulates VEGF (vascular endothelial growth factor) and FGF (fibroblast growth factor) to spark angiogenesis the creation of new blood vessels critical for healing
The choice between them is not arbitrary, but the reasoning differs depending on the delivery method
